George, Sydney
Carrico, Justin
Hicks, Katherine A.
Loukov, Dessi
Ng, Cheryl
Curran, Desmond
Funding for this research was provided by:
GlaxoSmithKline Biologicals (VEO-000059, VEO-000059, VEO-000059, VEO-000059, VEO-000059, VEO-000059)
Article History
Received: 21 November 2023
Accepted: 10 March 2025
First Online: 25 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: DL, IK, CN, and DC are employed by, and holds financial equities in GSK. SG is employed by GSK. JC and KH are employed by RTI - Health Solutions and their employer received consulting fees from GSK to perform the work contributing to this research. All authors declare no other financial and non-financial relationships and activities.